Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 310

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 310
---
 Company does not intend to correct or restate, nor, to the knowledge of the Company, is there any basis for any correction or restatement of any aspect of the Financial Statements.

| 9. | Off-Balance Sheet Financing |

Except as set forth in Schedule 9 of the Disclosure Letter, there are no off-balancesheet transactions, arrangements, obligations (including contingent obligations) or other relationships of the Company with unconsolidated entities or other persons.

| 10. | Independence of Auditors |

The auditors of the Company are independent public accountants as required under Canadian Securities Laws. There has not been a “reportable event” (within the meaning of applicable Securities Laws) with the present or any former auditor of the Company.

| 11. | Liabilities and Indebtedness |

| (b) | Except as disclosed in Schedule 11 to the Disclosure Letter, the Company is not party to or bound by or subject                                                                                                                                
 to: (i) any bond, debenture, promissory note, credit facility or other similar Contract evidencing indebtedness or potential indebtedness for borrowed money; or (ii) any Contract, whether written or oral, to create, assume or issue any of 
 the foregoing.                                                                                                                                                                                                                                 |

| 12. | Brokerage Fees |

| (a) | Except for the Financial Advisor, whose fees, commission and expenses are the sole responsibility of the                                                                                                                                             
 Company, and which have been disclosed to the Purchaser, the Company has not retained nor will it retain any financial advisory, broker, agent or finder or paid or agreed to pay any financial advisory, broker, agent or finder on account of this 
 Agreement or any transaction contemplated hereby. Other than the foregoing, the Company has not incurred any obligation or liability, contingent or otherwise, for brokerage fees, finders’ fees, agents’ commission or other similar forms          
 of compensation with respect to the transactions contemplated by this Agreement.                                                                                                                                                                     |

| (b) | The Company has delivered to the Purchaser true and correct copies of all agreements between the Company and 
 the Financial Advisor.                                                                                       |

| 13. | Books and Records |

| (a) | The financial books, records and accounts of the Company and its Subsidiary, in all material respects: |

| (i) | have been maintained in accordance with GAAP; |

| (ii) | are stated in reasonable detail and accurately and fairly reflect the transactions and dispositions of the 
 assets of the Company and